US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 14, 2022 (4 years ago)

TETRACAINE 1% Tetracaine HCI Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

What was recalled

TETRACAINE 1% Tetracaine HCI Injection, USP, 20mg/2mL (10mg/mL), 10 x 2ml Single Use Vials per box, Rx only, Manufactured for Cameron Pharmaceuticals, LLC., NDC 42494-437-10.

Recalling firm
Vitae Enim Vitae Scientific, Inc.
NDC code
42494-437-10
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0741-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Tetracaine recalls

See all
Class III · Low risk Terminated

LET Gel

Reason Product Mix-up: Incorrect Product Formulation

Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop NDC 73271-1003-1 D-0140-2024
Class II · Moderate risk Terminated

New & Improved Blue Gel Anesthetic

Reason cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.

HTO Nevada, Inc. D-0270-2023
Class II · Moderate risk Terminated

Tetracaine HCl Nasal Solution

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1195-03 D-0447-2022
Class II · Moderate risk Terminated

Profound-PE Dental Gel

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-0408-10 D-0442-2022